SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2094CC 8:30 tomorrow. Forbes' take adds color: >>Forbes take adds color:tuck-4/28/2004
2093Revenues a bit light, earnings about in line after extraordinary gain. Guidancetuck-4/28/2004
2092European Commission Grants Marketing Authorization to Millennium for VELCADE(R) manny t-4/27/2004
2091Neill Giese SGX Appoints Neill Giese, Ph.D. as Senior Vice President of Drug DeIcebrg-4/22/2004
2090PCSS, Even if you don't understand much of the science contained in that Metuck-4/21/2004
2089Michael, I didn't contribute anything, I was just admitting that I often fintom pope-4/21/2004
2088tom, tuck, Ian, .... I (and possibly others) thank you EXTREMELY much - quickPCSS-4/21/2004
2087<i>Just be thankful I don't post abstracts that are as cryptic as sometom pope-4/21/2004
2086In Lenz's section of the CME, he states, "Importantly, in this Phase I Ian@SI-4/21/2004
2085Just be thankful I don't post abstracts that are as cryptic as some of Rick&tuck-4/20/2004
2084Tuck, Ian, etc. NOT being an expert in the field (just a MLNM investor) - I wouPCSS-4/20/2004
2083[Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity otuck-4/20/2004
2082This is beginning to smell like Index Arbitrage where Merrill has a computer comIan@SI-4/17/2004
2081Ian, you were noting the strange odd lot fills on some of your trades. I've tom pope-4/17/2004
2080Yeah, I am still in the heavy net loss camp and may never pay taxes on cap gainsRobohogs-4/17/2004
2079Erik, Thanks, I wasn't into trading. During the recession, I acquired sufIan@SI-4/16/2004
2078Ian I am not at all into trading. I believe that an expansion of the use of VelIcebrg-4/16/2004
2077Hi Erik, I just finished acquiring a trading position in MLNM yesterday. Most oIan@SI-4/16/2004
2076ASCO abstracts. The ASCO abstracts are now available on-line at ASCO's siteIcebrg-4/16/2004
2075Roberto Guerciolini [There appears to be a fair number of people leaving MillenIcebrg-4/15/2004
2074The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synerIcebrg-4/9/2004
2073Yes. And the devils are in the details and management's ethics and sense ofquidditch-4/6/2004
2072<i> MLNM (IL/N): GS call 3/31 @10AM on cancer pipeline The Goldman Sachs microcapfun-4/4/2004
2071[MLN 519 for ischemia/reperfusion in BI] >>Stroke. 2004 Apr 1 [Epub aheadtuck-4/4/2004
2070OT: Butyric acid by itself is toxic. So, it has to be ester or something that wMiljenko Zuanic-4/4/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News